We are live on
!
Find out more
PCP
Pacific Capital Partners Portfolio holdings
AUM
$116M
1-Year Est. Return
24.59%
This Fund
S&P 500
This Quarter
Est. Return
+14.85%
1 Year Est. Return
+24.59%
3 Year Est. Return
+49.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$171M
AUM Growth
+$19.6M
(+13%)
Cap. Flow
-$381K
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
50.35%
Holding
58
New
–
Increased
11
Reduced
10
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$6.2M |
| 2 |
Blackstone Mortgage Trust
BXMT
|
+$1.93M |
| 3 |
CBIZ
CBZ
|
+$1.82M |
| 4 |
Woodward
WWD
|
+$1.66M |
| 5 |
PayPal
PYPL
|
+$1.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$3.15M |
| 2 |
BioLife Solutions
BLFS
|
+$2.42M |
| 3 |
Republic Services
RSG
|
+$1.94M |
| 4 |
Clean Harbors
CLH
|
+$1.76M |
| 5 |
ICU Medical
ICUI
|
+$1.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.46% |
| 2 | Industrials | 21.78% |
| 3 | Financials | 11.33% |
| 4 | Materials | 4.74% |
| 5 | Consumer Discretionary | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
BioLife Solutions
BLFS
$1.8B
| $1.82M | 1.06% |
72,500
-102,500
| -59% | -$2.42M |
|
27
Service Corp International
SCI
$11.3B
| $1.79M | 1.05% |
22,725
-2,017
| -8% | -$153K |
|
|
HOLX
28
DELISTED
Hologic
HOLX
| $1.79M | 1.05% |
21,974
-2,722
| -11% | -$218K |
|
29
Procept Biorobotics
PRCT
$1.25B
| $1.67M | 0.98% |
20,876
-3,423
| -14% | -$243K |
|
30
Carlyle Group
CG
$17.2B
| $1.64M | 0.96% |
38,074
| – | – |
|
31
Standard BioTools
LAB
$252M
| $1.59M | 0.93% |
825,000
+75,000
| +10% | +$147K |
|
32
Merck
MRK
$369B
| $1.55M | 0.91% |
13,681
+1,069
| +8% | +$127K |
|
33
Transmedics
TMDX
$3.22B
| $1.54M | 0.9% |
9,782
-1,774
| -15% | -$273K |
|
34
Thermo Fisher Scientific
TMO
$229B
| $1.46M | 0.85% |
2,358
| – | – |
|
35
Cooper Companies
COO
$14.9B
| $1.42M | 0.83% |
12,838
| – | – |
|
36
Brunswick
BC
$5.16B
| $1.29M | 0.75% |
15,343
| – | – |
|
|
AXNX
37
DELISTED
Axonics, Inc. Common Stock
AXNX
| $1.17M | 0.69% |
16,872
| – | – |
|
38
Eli Lilly
LLY
$1.12T
| $1.1M | 0.65% |
1,246
| – | – |
|
39
Boston Scientific
BSX
$73.5B
| $1.1M | 0.65% |
13,156
| – | – |
|
40
Strategic Education
STRA
$1.84B
| $1.05M | 0.61% |
11,339
+788
| +7% | +$79.7K |
|
41
HCA Healthcare
HCA
$88.1B
| $1.01M | 0.59% |
2,495
| – | – |
|
42
Fortrea Holdings
FTRE
$1.75B
| $1M | 0.59% |
50,000
| – | – |
|
43
EPAM Systems
EPAM
$5.52B
| $995K | 0.58% |
5,000
| – | – |
|
|
CVSA
44
Covista Inc
CVSA
$4.51B
| $966K | 0.57% |
12,803
| – | – |
|
45
Ameriprise Financial
AMP
$49.4B
| $939K | 0.55% |
1,998
| – | – |
|
46
Prestige Consumer Healthcare
PBH
$2.41B
| $901K | 0.53% |
12,500
| – | – |
|
47
Columbia Sportswear
COLM
$3.06B
| $875K | 0.51% |
10,523
| – | – |
|
48
Nike
NKE
$59.3B
| $705K | 0.41% |
7,972
| – | – |
|
49
Ecolab
ECL
$79.6B
| $677K | 0.4% |
2,653
| – | – |
|
50
Tandem Diabetes Care
TNDM
$1.62B
| $648K | 0.38% |
15,282
| – | – |
|
Similar funds
VWA
JBC
IIWM
JBI
BWM
SAM
ACA
VFM
Pacific Capital Partners's Q3 2024 Portfolio in Review
As of Q3 2024, Pacific Capital Partners held 58 positions worth $171M, up 13% from $151M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Pacific Capital Partners's Q3 2024 filing shows 11 increased, 10 reduced and 4 closed positions. The largest sale was Canadian Pacific Kansas City, an estimated $3.15M.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 50% a quarter earlier, followed by Industrials and Financials.
- Pacific Capital Partners added most to UnitedHealth in Q3 2024, an estimated $6.2M increase.
- Pacific Capital Partners's biggest Q3 2024 reduction was BioLife Solutions, cutting an estimated $2.42M.
- Pacific Capital Partners fully exited Canadian Pacific Kansas City in Q3 2024, selling an estimated $3.15M.
- Pacific Capital Partners's ten largest holdings make up 50% of its $171M portfolio in Q3 2024.
- Pacific Capital Partners opened 0 new positions and closed 4 in Q3 2024.
- Pacific Capital Partners's portfolio value rose 13% quarter-over-quarter to $171M.
Based on Pacific Capital Partners's 13F filing for Q3 2024, filed 8 May 2025.